妇科肿瘤单孔腹腔镜:单中心七年经验
该回顾性单中心研究纳入2009至2015年接受单孔腹腔镜手术的898例妇科肿瘤患者(共908次手术),中位随访37.2个月。30天内不良结局发生率低,切口疝发生率为5.5%,但美国麻醉医师学会III/IV级患者3年疝发生率为12.8%,糖尿病患者为23.0%。
要点
- 30天内不良结局发生率低:再手术0.1%、术中损伤1.4%、ICU入住0.4%、静脉血栓栓塞0.3%、输血0.8%。
- 切口疝发生率为5.5%(n=50),平均发生时间为570.2±553.3天。
- 美国麻醉医师学会III/IV级患者3年疝发生率为12.8%(HR 1.81),糖尿病患者为23.0%(HR 3.60)。
核心结论
- 在大规模单孔腹腔镜队列中,短期不良结局发生率低;切口疝发生率为5.5%,但高危组3年发生率可达23.0%。
- 既往随访时间短的研究可能低估疝风险,尤其是在有明显合并症的患者中。
研究设计与样本
- 回顾性单中心研究,纳入2009至2015年接受单孔腹腔镜手术的妇科肿瘤患者共898例、908次手术。
- 采用χ2检验和Student t检验进行单因素分析,用Kaplan-Meier法和Cox比例风险模型确定疝发生时间。
主要发现
- 中位随访37.2个月;平均年龄55.7岁,平均体重指数29.6 kg/m2;87.9%为白人,95.5%为美国麻醉医师学会II/III级。
- 手术指征主要为附件包块(36.9%)和子宫内膜增生/癌(37.3%);62.7%行子宫切除术,86%行单侧或双侧输卵管和/或卵巢切除。
- 30天内不良结局:再手术0.1%、术中损伤1.4%、ICU入住0.4%、静脉血栓栓塞0.3%、输血0.8%;尿路感染2.8%,切口蜂窝织炎3.5%,手术再入院3.4%。
- 切口疝发生率为5.5%(n=50),平均发生时间570.2±553.3天;美国麻醉医师学会分级较高(P=.04)、糖尿病(P<.001)、高血压(P=.043)、年龄增长(P=.017;HR 1.03)和体重指数(P<.001;HR 1.08)为独立预测因素。
- 既往腹部手术(P=.24)和手助(P=.64)与切口疝风险增加无关;美国麻醉医师学会III/IV级患者3年疝发生率为12.8%(HR 1.81),糖尿病患者3年疝发生率为23.0%(HR 3.60)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single-port laparoscopy has gained popularity within minimally invasive gynecologic surgery for its feasibility, cosmetic outcomes, and safety. However, within gynecologic oncology, there are limited data regarding short-term adverse outcomes and long-term hernia risk in patients undergoing single-port laparoscopic surgery. OBJECTIVE: The objective of the study was to describe short-term outcomes and hernia rates in patients after single-port laparoscopy in a gynecologic oncology practice. STUDY DESIGN: A retrospective, single-institution study was performed for patients who underwent single-port laparoscopy from 2009 to 2015. A univariate analysis was performed with χ2 tests and Student t tests; Kaplan-Meier and Cox proportional hazards determined time to hernia development. RESULTS: A total of 898 patients underwent 908 surgeries with a median follow-up of 37.2 months. The mean age and body mass index were 55.7 years and 29.6 kg/m2, respectively. The majority were white (87.9%) and American Society of Anesthesiologists class II/III (95.5%). The majority of patients underwent surgery for adnexal masses (36.9%) and endometrial hyperplasia/cancer (37.3%). Most women underwent hysterectomy (62.7%) and removal of 1 or both fallopian tubes and/or ovaries (86%). Rate of adverse outcomes within 30 days, including reoperation (0.1%), intraoperative injury (1.4%), intensive care unit admission (0.4%), venous thromboembolism (0.3%), and blood transfusion, were low (0.8%). The rate of urinary tract infection was 2.8%; higher body mass index (P = .02), longer operative time (P = .02), smoking (P = .01), hysterectomy (P = .01), and cystoscopy (P = .02) increased the risk. The rate of incisional cellulitis was 3.5%. Increased estimated blood loss (P = .03) and endometrial cancer (P = .02) were independent predictors of incisional cellulitis. The rate for surgical readmissions was 3.4%; higher estimated blood loss (P = .03), longer operative time (P = .02), chemotherapy alone (P = .03), and combined chemotherapy and radiation (P < .05) increased risk. The rate of incisional hernia rate was 5.5% (n = 50) with a mean occurrence at 570.2 ± 553.3 days. Higher American Society of Anesthesiologists class (P = .04), diabetes (P < .001), hypertension (P = .043), increasing age (P = .017; hazard ratio [HR], 1.03), and body mass index (P < .001; HR, 1.08) were independent predictors for incisional hernia development. Previous abdominal surgeries (P = .24) and hand assist (P = .64) were not associated with increased risk for incisional hernia. Patients with American Society of Anesthesiologists class III/IV had a 3 year hernia rate of 12.8% (HR, 1.81). Patients with diabetes mellitus had a 3 year hernia rate of 23.0% (HR, 3.60). CONCLUSION: In this large cohort of patients undergoing single-port laparoscopy, the incidence of short-term adverse outcomes is low. While the rate of incisional hernia was 5.5%, incidence reached 23.0% at 3 years in high-risk groups. Previous studies with short follow-up duration may underestimate the risk of hernia, especially in patients with significant comorbidities.
引用
- Moulton L, Jernigan AM, Carr C, et al. Single-port laparoscopy in gynecologic oncology: seven years of experience at a single institution. Am J Obstet Gynecol. 2017. PMID: 28619688. doi:10.1016/j.ajog.2017.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。